Over the last two decades, an increasing number of studies have evidenced the diagnostic and prognostic role of procalcitonin (PCT) in discriminating between bacterial, viral or other non-bacterial infection, sepsis and systemic inflammation [1] across a variety of clinical scenarios, in both adult and pediatric populations [2]. The gene discussed is CALCA; the disease is bacterial infectious disease.